TOPICAL MEK INHIBITOR PROGRAMS
Program | Preclinical | Phase 1 | Phase 2 | Phase 3 |
---|---|---|---|---|
Neurofibromatosis Type 1 Treatment of Cutaneous Neurofibromas | ||||
Squamous Cell Carcinoma Prevention in High-Risk Transplant Recipients | ||||
Congenital Birthmarks Non-surgical Treatment |
Program | Stage | |
---|---|---|
Neurofibromatosis Type 1tar | Treatment of Cutaneous Neurofibromas | Phase 2 |
Squamous Cell Carcinoma | Prevention in High-Risk Transplant Recipients | Preclinical |
Congenital Birthmarks | Non-surgical Treatment | Preclinical |